ClinicalTrials.gg
Biological

Vonicog alfa clinical trials

Also written VONVENDI, BAX 111 and TAK-577.

studies test it
8
open now
2
in phase 3
8
first study started
2011

How each study uses vonicog alfa is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the vonicog alfa studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
8 Dec 2015 · Vonvendi · BLA 125577 (FDA, Purple Book)
European Union
31 Aug 2018 · Veyvondi · EMEA/H/C/004454 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

vonicog alfa
6
rVWF
5
Recombinant von Willebrand Factor (rVWF)
3

Brand

VONVENDI
5

Development codes

BAX 111
3
TAK-577
3
SHP677
1

Other names

von Willebrand factor (Recombinant)
1

Studies by the year they started

8 studies that test it; most in 2017 (2)

Studies that test vonicog alfa, by start year
YearStudies
20111
20151
20172
20192
20241
20251

By phase

A phase 1/2 study counts in both.

Phase 3
8

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 7 · Other 1

Baxalta now part of Shire (4) · Takeda (3) · Margaret Ragni (1)

Often tested with

Tested in the same studies.

Antihemophilic factor, human recombinant (2) · F8 protein, human (1) · Tranexamic Acid (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1, 1 in phase 3

Studies that test vonicog alfa, phase 3 first.

Studies

Open first, then newest update. How each study uses vonicog alfa is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 8

Codes

What other systems call vonicog alfa · ClinicalTrials.gg INT015103

  • UNII (FDA) 5PKM8P0G5IVONICOG ALFAConfirmed FDA, Wikidata
  • RxNorm 1812589Confirmed FDA, Wikidata
  • Wikidata Q96414099vonicog alfaConfirmed FDA, Wikidata
  • NCI Thesaurus C152910Vonicog AlfaOne source FDA
  • DrugBank DB12872One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.